basal insulin and glp-1 Glucometabolic outcomes of receptor agonist-based therapies in patients with type 2 diabetes: a systematic review network meta-analysis glp-1_analogs [TUSOM | Pharmwiki]
Pay in 4 interest-free payments of $6.38 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
![basal insulin and glp-1 Glucometabolic outcomes of receptor agonist-based therapies in patients with type 2 diabetes: a systematic review network meta-analysis glp-1_analogs [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/glp1.png?w=600&tok=baf39c)
![basal insulin and glp-1 Glucometabolic outcomes of receptor agonist-based therapies in patients with type 2 diabetes: a systematic review network meta-analysis glp-1_analogs [TUSOM | Pharmwiki]](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12933-021-01414-3/MediaObjects/12933_2021_1414_Fig1_HTML.png)
![basal insulin and glp-1 Glucometabolic outcomes of receptor agonist-based therapies in patients with type 2 diabetes: a systematic review network meta-analysis glp-1_analogs [TUSOM | Pharmwiki]](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25f8/10786682/c9c407a78e3d/jci-134-175634-g205.jpg)
![basal insulin and glp-1 Glucometabolic outcomes of receptor agonist-based therapies in patients with type 2 diabetes: a systematic review network meta-analysis glp-1_analogs [TUSOM | Pharmwiki]](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41392-024-01931-z/MediaObjects/41392_2024_1931_Fig1_HTML.png)





















